NasdaqGS:BTSG
NasdaqGS:BTSGHealthcare

BrightSpring Health Services (BTSG): Assessing Valuation After a Strong 90-Day Share Price Rally

BrightSpring Health Services (BTSG) has been quietly rewarding patient shareholders, with the stock climbing about 41% over the past 3 months and more than doubling year to date. This performance is prompting closer attention to what is driving the move. See our latest analysis for BrightSpring Health Services. With the share price now at $37.73 and a 90 day share price return of about 41%, the momentum behind BrightSpring looks firmly upward. This reinforces a strong year to date share price...
NYSE:BSX
NYSE:BSXMedical Equipment

Does Boston Scientific’s Strong Run Match Its Current Valuation in 2025?

If you have been wondering whether Boston Scientific is still a smart buy after its big run in recent years, this breakdown will help you decide if the current price actually makes sense. The stock is up 110.0% over 3 years and 170.4% over 5 years, while more recently it is up 1.7% in the last week, down 1.9% over 30 days, and sitting on a 7.6% gain year to date plus a 5.6% return over the last year. Behind these moves, investors have been digesting continued momentum in Boston Scientific's...
NYSE:BAH
NYSE:BAHProfessional Services

Assessing Booz Allen Hamilton’s Valuation After Its Addition to the S&P 1000 Index

Booz Allen Hamilton Holding (BAH) just secured a spot in the S&P 1000, a move that can quietly change the stock’s demand profile as index trackers and small cap managers adjust their allocations. See our latest analysis for Booz Allen Hamilton Holding. The S&P 1000 inclusion comes after a choppy stretch, with the share price at $85.15 and a roughly 5 percent 1 month share price return, but a weaker year to date share price return alongside a negative 1 year total shareholder return. This...
NasdaqGS:SEIC
NasdaqGS:SEICCapital Markets

SEI Investments (SEIC): Assessing Valuation as Founder Alfred West Prepares to Hand Over the Chairmanship

SEI Investments (SEIC) just hit a major milestone, as founder Alfred P. West, Jr. prepares to step down as Executive Chairman and director on January 1, 2026, handing the chair role to Carl A. Guarino. See our latest analysis for SEI Investments. The leadership handover comes as SEI Investments trades at $85.37, with a 30 day share price return of 7.60 percent pointing to building momentum, while a three year total shareholder return near 53 percent underlines its longer term wealth...
NasdaqGS:FISV
NasdaqGS:FISVDiversified Financial

Fiserv (FISV) Valuation Check After New AI-Powered Visa Partnership in Agentic Commerce and Trusted Agent Protocol

Fiserv (FISV) just unveiled a high profile collaboration with Visa to roll out AI driven agentic commerce and the Trusted Agent Protocol across its merchant network, signaling a meaningful upgrade to its payment security capabilities. See our latest analysis for Fiserv. Despite this ambitious Visa collaboration and other moves like new co brand processing mandates and leadership changes in investor relations, Fiserv’s momentum has been mixed, with a sharp year to date share price return...
NYSE:WM
NYSE:WMCommercial Services

Evaluating Waste Management (WM)’s Valuation After Its 2026 Dividend Hike and New $3 Billion Buyback Program

Waste Management (WM) just doubled down on being a shareholder friendly utility-like stock by rolling out a 14.5% dividend hike for 2026 alongside a fresh $3 billion buyback authorization. See our latest analysis for Waste Management. The shareholder friendly playbook appears to be resonating, with the stock’s recent 1 month share price return of 4.5 percent building on a solid 10.4 percent year to date share price gain and a 5 year total shareholder return above 100 percent. This suggests...
OTCPK:SWRD
OTCPK:SWRDDiversified Financial

Stewards (SWRD) Valuation Check After Governance Shake‑Up and Planned Nasdaq Uplisting

Stewards (OTCPK:SWRD) just gave investors a fresh governance catalyst by appointing veteran finance executive John Bode as board member and audit committee chair as the company gears up for a planned Nasdaq uplisting. See our latest analysis for Stewards. The governance upgrade is landing just as momentum in Stewards' shares has accelerated, with a 1 day share price return near 20 percent, a roughly 46 percent 1 month share price return, and a powerful year to date share price return above...
NasdaqGS:LULU
NasdaqGS:LULULuxury

Lululemon (LULU): Reassessing Valuation After a 24% One-Month Share Price Rebound

lululemon athletica (LULU) has been on a sharp rebound recently, with the stock climbing about 24% over the past month and 22% in the past 3 months after a tough year. See our latest analysis for lululemon athletica. That sharp rebound stands in contrast to a tough stretch, with the share price still well below its early year levels despite the recent 1 month share price return of roughly 24 percent. This suggests sentiment may be stabilizing rather than fully turning. If lululemon’s move has...
NasdaqGS:CCOI
NasdaqGS:CCOITelecom

A look at Cogent Communications (CCOI) valuation after dividend slash, revenue decline and fresh legal scrutiny

Dividend shock and legal scrutiny reshape the picture for Cogent Communications Holdings Cogent Communications Holdings (CCOI) just slashed its dividend by 98% and reported service revenue down about 6% year over year. This combination sent the stock tumbling and triggered a fresh securities law investigation. See our latest analysis for Cogent Communications Holdings. The sudden 98 percent dividend cut and revenue slip come on top of a brutal stretch, with Cogent’s share price down about 71...
NasdaqGS:AGIO
NasdaqGS:AGIOBiotechs

Why Agios Pharmaceuticals (AGIO) Is Up 14.6% After First-in-Class Thalassemia Drug AQVESME Wins FDA Approval

Agios Pharmaceuticals has now received U.S. FDA approval for AQVESME (mitapivat) to treat anemia in adults with alpha- or beta-thalassemia, covering both non-transfusion-dependent and transfusion-dependent patients, with U.S. availability expected after implementation of a required REMS program in late January 2026. The approval, grounded in positive ENERGIZE and ENERGIZE-T Phase 3 data showing reduced transfusion burden and better quality-of-life measures, transforms AQVESME into a new...
NYSE:LEVI
NYSE:LEVILuxury

A Look at Levi Strauss’s Valuation After New Outperform Rating and Board Appointment Boost Optimism

Levi Strauss (LEVI) is back on investors radar after two developments landed almost at once: fresh Outperform coverage from Raymond James and the upcoming board appointment of veteran executive Jeffrey J. Jones II. See our latest analysis for Levi Strauss. At around $21.18 per share, Levi’s recent 1 day and year to date share price gains sit against a still solid 1 year total shareholder return of about 25 percent. This suggests momentum has cooled a bit rather than reversed, as investors...
NYSE:GNL
NYSE:GNLREITs

How Investors May Respond To Global Net Lease (GNL) McLaren Campus Sale And Preferred Dividend Payouts

Global Net Lease, Inc. recently declared quarterly dividends on its Series A, B, D, and E preferred stocks, payable on January 15, 2026 to holders of record as of January 2, 2026. The company also closed the sale of the McLaren Campus in Woking, England for £250,000,000, realizing an approximately £80,000,000 gain and reinforcing its capital recycling and balance sheet strengthening efforts. We’ll now examine how this sizeable McLaren Campus sale, with its balance sheet impact, could...
NYSE:COP
NYSE:COPOil and Gas

How Investors May Respond To ConocoPhillips (COP) LNG And Willow-Focused Free Cash Flow Strategy

Earlier in 2025, commentary highlighted ConocoPhillips’ clear plan to grow free cash flow through LNG investments and the Willow oil project in Alaska, supporting dividends and share repurchases as peers such as Occidental Petroleum focused more on debt reduction. An important angle is that ConocoPhillips is being framed as a comparatively stronger vehicle for shareholder value growth because its capital allocation roadmap and project pipeline are perceived as more clearly defined than some...
NYSE:COTY
NYSE:COTYPersonal Products

Coty (COTY) Is Down 6.1% After Naming Markus Strobel Interim CEO And Selling Wella Stake

Coty Inc. recently announced that Procter & Gamble veteran Markus Strobel will become Interim CEO and Executive Chairman on January 1, 2026, succeeding outgoing CEO Sue Nabi and long-time Executive Chair Peter Harf after their multi-year tenures. The leadership reshuffle comes as Coty completes the sale of its remaining Wella stake to KKR for US$750,000,000 and confronts pressure on its consumer beauty operations, prompting a broad strategic review. We’ll now examine how Strobel’s dual role...
NYSE:CIEN
NYSE:CIENCommunications

Is It Too Late To Consider Ciena After Its 189% Surge In 2025?

If you are wondering whether Ciena is still a buy after its huge run, you are not alone. This piece will focus on what the current price might be baking in. The stock has surged roughly 17.8% over the last week, 23.4% over the past month, and is up an eye catching 188.7% year to date. That builds on multi year gains of 173.3% over 1 year, 389.2% over 3 years, and 357.8% over 5 years. Behind those moves, investors have been reacting to a steady drumbeat of positive sentiment around optical...
NYSE:JPM
NYSE:JPMBanks

JPMorgan (JPM) Valuation Check After 10% Monthly Gain and 39% One-Year Share Price Rally

Event driven move in JPMorgan Chase stock JPMorgan Chase (JPM) has been grinding higher, with the stock now up about 10 % over the past month and roughly 39 % over the past year, outpacing many large bank peers. See our latest analysis for JPMorgan Chase. The latest climb in JPMorgan Chase shares, with a 30 day share price return of just over 10 % and a 1 year total shareholder return approaching 39 %, points to momentum building as investors increasingly price in durable earnings power...
NasdaqGS:WDC
NasdaqGS:WDCTech

Western Digital (WDC) Is Up 8.0% After Nasdaq-100 Addition And AI Storage Pivot - Has The Bull Case Changed?

Western Digital Corporation was added to the Nasdaq-100 index on December 22, 2025, following its spin-off of the Flash business into a separate SanDisk entity and renewed focus on high-capacity hard disk drives for AI and cloud data centers. This combination of index inclusion and a sharpened AI-centric storage model is reshaping Western Digital’s role in large-scale data infrastructure and how investors view its long-term earnings power, capital returns, and risk profile. Next, we’ll...
NasdaqGS:METC
NasdaqGS:METCMetals and Mining

Taking a Fresh Look at Ramaco Resources (METC) Valuation After Its New $100 Million Share Buyback Program

Ramaco Resources (METC) just put real money behind its optimism, rolling out a $100 million share repurchase program over the next two years after completing sizable capital raises earlier this year. See our latest analysis for Ramaco Resources. The buyback news lands as the share price has rebounded to $18.18, with a 7 day share price return of 30.04 percent and a year to date share price return of 69.75 percent. A 1 year total shareholder return of 82.68 percent and 5 year total shareholder...
NYSE:DE
NYSE:DEMachinery

Is Deere’s Recent Share Price Pause Creating a Long Term Opportunity in 2025

How Has Deere's Share Price Been Performing? After a strong multi year run, Deere's share price has been more range bound recently, which can make it harder for investors to judge whether the current level really offers good value. To set the scene for a valuation deep dive, it helps to look at how the stock has actually been behaving. Over the last year, Deere has delivered a total return of 9.5%, with shares up 11.8% year to date despite some recent softness. In the shorter term, the stock...
NasdaqGS:TW
NasdaqGS:TWCapital Markets

Does Tradeweb Still Offer Value After Recent Gains Despite Weak Valuation Signals?

If you are wondering whether Tradeweb Markets at around $107 a share still offers value or if most of the upside is already priced in, you are not alone. The stock has crept higher in the short term, up about 2.5% over the last week and 2.0% over the past month, even though it is still down roughly 18.3% year to date and 19.8% over the last year, following a strong 68.5% gain over three years and 77.7% over five years. Recent moves have come as investors refocus on Tradeweb's structural role...
NasdaqGS:UCTT
NasdaqGS:UCTTSemiconductor

Ultra Clean Holdings (UCTT) Valuation After Zacks Rank #2 (Buy) Upgrade and Rising Earnings Estimates

Ultra Clean Holdings (UCTT) just picked up a Zacks Rank #2 (Buy) upgrade after analysts raised their earnings estimates, which is a clear signal that expectations for the company’s near term profit trajectory are improving. See our latest analysis for Ultra Clean Holdings. The upgrade lands after a choppy stretch, with the share price at 26.18 dollars and a 30 day share price return of 13.58 percent contrasting with a weaker year to date share price return and similarly negative one year...
NYSE:ALB
NYSE:ALBChemicals

Has Albemarle’s 74% Rally in 2025 Already Priced In Its Lithium Recovery Story?

If you are wondering whether Albemarle is a bargain or a value trap at today’s price, you are not alone. This piece will walk through what the current market is really baking in. After a tough few years, the stock has bounced hard, climbing 10.2% over the last week, 28.2% over the past month, and an impressive 74.2% year to date, although the 3 year return is still down 27.5% with just 5.5% over 5 years. That swingy profile has been driven by shifting expectations around long term lithium...
NYSE:BFAM
NYSE:BFAMConsumer Services

Is Bright Horizons’ Q3 Earnings Beat and Strong Core Operations Altering The Investment Case For Bright Horizons Family Solutions (BFAM)?

Earlier this year, Bright Horizons Family Solutions posted a third-quarter revenue increase that surpassed analyst expectations by 2.9%, alongside stronger-than-expected organic revenue and adjusted operating income. This outperformance relative to forecasts underscores the strength of Bright Horizons’ core operations at a time when investors were closely watching its execution. We’ll now examine how this earnings beat, particularly the upside in adjusted operating income, may influence...
NasdaqGS:KRYS
NasdaqGS:KRYSBiotechs

Does Krystal Biotech Still Offer Value After Its Strong Share Price Run?

How does Krystal Biotech look on traditional valuation checks To get a clearer handle on whether Krystal Biotech still offers value after such a strong run, it helps to strip things back to the fundamentals and run through a few well known valuation lenses. Here we will walk through how the stock stacks up on simple metrics like price to earnings, price to sales, and price to book, then layer in expectations of future growth to see if the current share price can be justified. Starting with...